These suppressive mechanisms include inhibitory cytokines [10] as well as the shedding of NK cell activating ligands from the tumor cell surface, which blocks activating NK cell receptors, such as NKG2D [11–13]. The gene discussed is KLRD1; the disease is neoplasm.